To Compare the Efficacy and Safety of INS068 and Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Not Adequately Controlled With Oral Antidiabetic Drugs
Clinical trial NCT05699408 · COMPLETED
Trial details
- NCT number
- NCT05699408
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-31
- Primary completion
- 2024-11-23
- Enrollment
- 513
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.